| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143373 Quinolone carboxylic acid-substituted rifamycin derivatives |
| 06/04/2009 | US20090143356 Polycylclic Carbamoylpyridone Derivative Having HIV Integrase Inhibitory Acitvity |
| 06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
| 06/04/2009 | US20090143335 Modified absorption formulation of gaboxadol |
| 06/03/2009 | EP2065388A1 Pyrazolopyrimidine derivative |
| 06/03/2009 | EP2065386A1 CGRP antagonists |
| 06/03/2009 | EP2064212A1 Pyrrolo isoquinolines as kinase inhibitors |
| 06/03/2009 | EP2063889A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/03/2009 | EP1910381B1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs |
| 06/03/2009 | EP1838715A4 Method for the preparation of maytansinoid esters |
| 06/03/2009 | CN101448841A 39-desmethoxy-39-methyl derivatives of rapamycin |
| 06/03/2009 | CN101445510A Pyridine macrocyclic crown ether-based stilbene compound |
| 06/03/2009 | CN101445509A Sugar spiro-heterocycle compound with anti-tumor activity and preparation method thereof |
| 06/02/2009 | US7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
| 05/28/2009 | US20090137798 Process for the Preparation of Delmopinol and Derivatives Thereof |
| 05/28/2009 | US20090137597 Novel quinoxalinone derivatives |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents |
| 05/28/2009 | US20090137552 Organic Compound |
| 05/28/2009 | US20090137551 Substituted Bicyclolactam Compounds |
| 05/28/2009 | US20090137495 Organic Compounds and Their Uses |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136499 RAF Inhibitors and Uses Thereof |
| 05/28/2009 | US20090136449 Tetracyclic Indole Derivatives as Antiviral Agents |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/27/2009 | EP2062893A1 Fused imidazoles for cancer treatment |
| 05/27/2009 | EP2062891A1 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2061797A1 Therapeutic methods using wrn binding molecules |
| 05/27/2009 | EP1679747B1 Organic thin film transistor |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | CN101443314A Aminoquinolones as GSK-3 inhibitors |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/26/2009 | US7538122 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one |
| 05/26/2009 | US7538119 Metabolically resistant 41-[13C]methoxyl rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (41-[13C]methoxyl CCI-779); study pharmacokinetics; Rapamycin 31-O-trimethyl silyl ether, 42-ester with 2,2,5-trimethyl[1,3-dioxane]-5-carboxylic acid; treat cancers |
| 05/26/2009 | US7538108 N4-(2,2-dimethyl-4-[(di-tert-butyl phosphonoxy)methyl]-3-oxo-5-pyrido [1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; Syk tyrosine kinase inhibitor; collagen-induced platelet activation inhibitor; anitinflammatory agent; autoimmune diseases; bioavailability |
| 05/26/2009 | CA2429020C Use of cci-779 as an antineoplastic agent |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064792A1 Quinolone carboxylic acid-substituted rifamycin derivatives |
| 05/22/2009 | WO2009064675A1 Mapk/erk kinase inhibitors |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009062990A2 Equilibrative nucleoside transporter ent1 inhibitors |
| 05/22/2009 | WO2009037542A3 Spirocyclic compounds as stearoyl coa desaturase inhibitors |
| 05/22/2009 | WO2009010260A3 Condensed anthranilamide insecticides |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705452A1 Mapk/erk kinase inhibitors |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2704423A1 Equilibrative nucleoside transporter ent1 inhibitors |
| 05/21/2009 | US20090131661 Oxazolone Derivatives |
| 05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
| 05/21/2009 | US20090131445 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents |
| 05/21/2009 | US20090131436 Pyrimidine Derivatives |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
| 05/21/2009 | US20090131402 Fused heterocyclic compound and use thereof |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/20/2009 | EP2060272A2 Vitamin-mitomycin conjugates |
| 05/20/2009 | CN101437816A 2-aminopyridine analogs as glucokinase activators |
| 05/20/2009 | CN101437512A Glucokinase activators |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/19/2009 | US7534902 Blocking group(s) is released by reaction with trigger (phosphatase); optionally contains urea-containing group for attaching proteins, peptides or nucleic acids; rhodamine; kits |
| 05/19/2009 | US7534871 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 05/19/2009 | US7534767 4-amino-7-(2-C-methyl- beta -D-ribofuranosyl)-furo[3,2-d]pyrimidine; 7-amino-3-(2-C-methyl- beta -D-ribofuranosyl)-1H-pyrazolo[4,3-d]pyrimidine; -amino-7-(2-C-methyl- beta -D-ribofuranosyl)-5H-pyrrolo[3,2-d]pyrimidine; hepatitis C virus (HCV) infection |
| 05/14/2009 | WO2009061699A1 Gamma secretase modulators |
| 05/14/2009 | WO2009061595A1 Compounds for inhibiting ksp kinesin activity |
| 05/14/2009 | WO2008144507A3 Spirooxindole inhibitors of aurora kinase |
| 05/14/2009 | WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 05/14/2009 | WO2007067711A3 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 05/14/2009 | US20090124661 Hcv ns3 protease inhibitors |
| 05/14/2009 | US20090124637 Novel 5,7-Disubstituted [1,3]Thiazolo[4,5-D]Pyrimidin-2(3H)-One Derivatives 794 |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | US20090124597 such as oxazoline spiro-dibenzosuberenone compounds; cardiovascular, metabolic, immune disorders |
| 05/14/2009 | US20090124595 Mapk/erk kinase inhibitors |
| 05/14/2009 | US20090124580 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades |
| 05/14/2009 | US20090123805 Naphthoxazine benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode |
| 05/14/2009 | US20090123425 Macrocyclic, pyridazinone-containing hepatitis c serine protease inhibitors |
| 05/14/2009 | CA2704698A1 Gamma secretase modulators |
| 05/14/2009 | CA2702985A1 Compounds for inhibiting ksp kinesin activity |
| 05/13/2009 | EP2057133A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | CN101429200A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 05/12/2009 | US7531660 1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | CA2348890C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 05/12/2009 | CA2322027C Use of macrolide compounds for the treatment of ards |
| 05/07/2009 | WO2008153792A3 Gamma secretase modulators |
| 05/07/2009 | US20090118232 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 05/07/2009 | US20090117440 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode |
| 05/06/2009 | EP2055706A1 Naphthoxazine benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode |
| 05/06/2009 | EP2054422A1 Acrylamide derivatives as fab i inhibitors |
| 05/06/2009 | EP2054414A2 Imidazole amines as inhibitors of beta-secretase |